EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations?

Undurti N Das

Lipids in Health and Disease · 2024

DOI: 10.1186/s12944-024-02090-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Lipids in Health and Disease, 2024. Verfasst von Undurti N Das. Beteiligte Einrichtung: UND Life Sciences, 2221 NW 5th St, Battle ground, WA, 98604, USA. undurti@hotmail.com. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is hypothesized that COVID-19, post-COVID and post-mRNA COVID-19 (and other related) vaccine manifestations including “long haul syndrome” are due to deficiency of essential fatty acids (EFAs) and dysregulation of their metabolism. This proposal is based on the observation that EFAs and their metabolites can modulate the swift immunostimulatory response of SARS-CoV-2 and similar enveloped viruses, suppress inappropriate cytokine release, possess cytoprotective action, modulate serotonin and bradykinin production and other neurotransmitters, inhibit NF-kB activation, regulate cGAS-STING pathway, modulate gut microbiota, inhibit platelet activation, regulate macrophage and leukocyte function, enhance wound healing and facilitate tissue regeneration and restore homeostasis. This implies that administration of EFAs could be of benefit in the prevention and management of COVID-19 and its associated complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Fatty Acids, EssentialSyndromeInflammation

Stichwörter der Autor:innen

COVID-19EicosanoidsEssential fatty acidsInflammationLipoxin A4MaresinsPolyunsaturated fatty acidsProtectinsResolvinsSARS-CoV-2

Substanzen

Fatty Acids, Essential

Autor:innen und Institutionen

  • UND Life Sciences, 2221 NW 5th St, Battle ground, WA, 98604, USA. undurti@hotmail.com.
  • Department of Biotechnology, Indian Institute of Technology-Hyderabad, Sangareddy, Telangana, India. undurti@hotmail.com.
  • Department of Immunology and Rheumatology, Arete Hospitals, Gachibowli, Hyderabad, 4500032, India. undurti@hotmail.com.

Zitieren

APA

Das, U. N. (2024). Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations?. Lipids in Health and Disease. https://doi.org/10.1186/s12944-024-02090-4

Vancouver

Das UN. Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations?. Lipids in Health and Disease. 2024. doi:10.1186/s12944-024-02090-4

BibTeX
@article{Das2024,
  author = {Das, Undurti N},
  title = {Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations?},
  journal = {Lipids in Health and Disease},
  year = {2024},
  doi = {10.1186/s12944-024-02090-4}
}
Kostenlos starten →